Sort
39,280 grants matching “leukemia”
Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia
$395,400Matthew S Davids · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
$395,380Jerome Ritz · Dana-Farber Cancer Inst · UG1 · FY2019 · EY
The Contribution ofInfection to Preleukemic Clonal Hematopoiesis
$395,316Katherine Yudeh King · Baylor College Of Medicine · R01 · FY2018 · HL
Function of PHD Domain Proteins in Chromatin Regulation
$395,313Or P. Gozani · Stanford University · R01 · FY2017 · GM
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy
$395,245Suresh Kumar · National Institute On Aging · ZIA · FY2019 · AG
A chromatin-based timer controlling T-cell development
$395,224Hao Yuan Kueh · University Of Washington · R01 · FY2020 · HL
Formaldehyde Genotoxicity
$395,218Anatoly Zhitkovich · Brown University · R01 · FY2014 · ES
Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia
$395,211Xiaotu Ma · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Novel adoptive transfer therapy for glioma using CAR-transduced Type17 T-cells
$395,208Hideho Okada · University Of California, San Francisco · R21 · FY2014 · NS
MEMBRANES AND SIGNAL TRANSDUCTION
$395,207Salk Institute For Biological Studies · R01 · FY2001 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
$395,155St. Jude Children'S Research Hospital · R01 · FY2000 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$395,126Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2016 · MH
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$395,126Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2015 · MH
Redefining the major peanut allergens
$395,113Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2008 · AI
Chemo-Immunotherapy in Relapsed/Refactory B-Chronic Lymphocytic Leukemia
$395,110Neil E Kay · Mayo Clinic Rochester · R01 · FY2007 · CA
CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies
$395,087Gianpietro Dotti · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma
$395,006Michael D Hogarty · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Biochemical Basis of Chromatin Folding and Chromosome Condensation
$395,000Kyle Patrick Eagen · Northwestern University At Chicago · DP5 · FY2017 · OD
Biochemical Basis of Chromatin Folding and Chromosome Condensation
$395,000Kyle Patrick Eagen · Northwestern University At Chicago · DP5 · FY2020 · OD
Mechanisms of necrosis regulation of hematopoietic stem cell function
$395,000Sandra S Zinkel · Vanderbilt University Medical Center · R01 · FY2019 · HL
Mechanisms of necrosis regulation of hematopoietic stem cell function
$395,000Sandra S Zinkel · Vanderbilt University Medical Center · R01 · FY2020 · HL
Biochemical Basis of Chromatin Folding and Chromosome Condensation
$395,000Kyle Patrick Eagen · Northwestern University At Chicago · DP5 · FY2019 · OD
Mechanisms of necrosis regulation of hematopoietic stem cell function
$395,000Sandra S Zinkel · Vanderbilt University Medical Center · R01 · FY2021 · HL
Biochemical Basis of Chromatin Folding and Chromosome Condensation
$395,000Kyle Patrick Eagen · Northwestern University At Chicago · DP5 · FY2018 · OD
Development Of P2Y Receptor Ligands
$394,998Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK